Definitive Healthcare (DH) to Release Quarterly Earnings on Thursday

Definitive Healthcare (NASDAQ:DH) is expected to be issuing its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of $0.06 per share and revenue of $59.5660 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 26, 2026 at 5:00 PM ET.

Definitive Healthcare Stock Performance

Shares of DH opened at $1.57 on Thursday. Definitive Healthcare has a one year low of $1.52 and a one year high of $5.39. The company has a market cap of $221.94 million, a PE ratio of -0.94 and a beta of 1.59. The stock has a 50-day moving average of $2.31 and a 200-day moving average of $2.99. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.60 and a quick ratio of 1.60.

Institutional Investors Weigh In On Definitive Healthcare

A number of institutional investors have recently added to or reduced their stakes in DH. XTX Topco Ltd lifted its position in shares of Definitive Healthcare by 57.5% during the 4th quarter. XTX Topco Ltd now owns 75,306 shares of the company’s stock worth $216,000 after buying an additional 27,495 shares in the last quarter. Occudo Quantitative Strategies LP bought a new position in shares of Definitive Healthcare in the fourth quarter valued at approximately $95,000. Millennium Management LLC increased its position in shares of Definitive Healthcare by 230.9% during the fourth quarter. Millennium Management LLC now owns 332,087 shares of the company’s stock valued at $953,000 after acquiring an additional 231,743 shares during the last quarter. Inspire Investing LLC lifted its holdings in Definitive Healthcare by 505.7% during the fourth quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock worth $2,006,000 after acquiring an additional 583,562 shares during the period. Finally, Boothbay Fund Management LLC purchased a new position in Definitive Healthcare in the fourth quarter worth $92,000. 98.67% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on DH shares. Canaccord Genuity Group decreased their price objective on Definitive Healthcare from $5.00 to $4.00 and set a “hold” rating for the company in a report on Monday, November 10th. Barclays reduced their price target on shares of Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating for the company in a research report on Monday, December 8th. Wall Street Zen downgraded shares of Definitive Healthcare from a “strong-buy” rating to a “buy” rating in a report on Sunday, December 28th. Morgan Stanley reiterated an “underperform” rating and set a $3.50 price objective on shares of Definitive Healthcare in a report on Thursday, December 18th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, three have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $3.94.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.